Peter Evan Harwin, Director, 10% Owner at CRESCENT BIOPHARMA, INC. (CBIO), bought 1,360,000 shares at $13.41 ($18.2M) on 2025-12-04, disclosed to the SEC on 2025-12-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ZBIO | BUY | 2024-09-16 | $5.1M | — | Filing → |
| DNTH | BUY | 2023-10-03 | $673K | — | Filing → |